FIELD: medicine.
SUBSTANCE: bone marrow is sampled from breast; the sample is prepared for analysis and microscopic study in at least 50 fields of vision, in each of which a number of clusters consisting at least of three plasma cells is determined. Further, an evaluation index is described as an arithmetical mean derived from division of all clusters found on a number of the counted fields. If the index is less than 1, an avascular type of the clinical course of multiple myeloma is stated, while the value of this index exceeding 1 enables to state a vascular type of the clinical course of multiple myeloma.
EFFECT: use of the method allows diagnosing a type of the clinical course of multiple myeloma at the earliest stage that shall provide substantially higher clinical effectiveness.
4 dwg, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF DETERMINING EFFICIENCY OF MULTIPLE MYELOMA TREATMENT | 2013 |
|
RU2549458C1 |
| METHOD OF DETERMINING THE RISK GROUP FOR PATIENTS WITH MULTIPLE MYELOMA COMPLICATED BY PLASMACYTOMA | 2022 |
|
RU2801094C1 |
| METHOD OF TREATING INFLAMMATORY EXUDATIVE POSTOPERATIVE REACTIONS FOLLOWING IMPLANTATION OF INTRAOCULAR LENS | 2008 |
|
RU2381775C1 |
| METHOD OF DIAGNOSIS OF MYELODYSPLASTIC SYNDROME | 2017 |
|
RU2657840C1 |
| CHIMERIC ANTIGEN RECEPTOR | 2014 |
|
RU2684713C2 |
| METHOD FOR PREDICTING THE COURSE OF CLEAR CELL RENAL CELL CARCINOMA | 2022 |
|
RU2792250C1 |
| METHOD OF TREATING T-CELL LYMPHOMAS AND KAPOSIS'S SARCOMA | 2009 |
|
RU2401671C1 |
| METHOD FOR ESTIMATION OF BONE MARROW ASPIRATION QUALITY DURING MONITORING OF MINIMUM RESIDUAL DISEASE IN CASE OF MULTIPLE MYELOMA | 2016 |
|
RU2639382C1 |
| METHOD FOR PREDICTION OF CLINICAL COURSE OF PULMONARY ADENOCARCINOMA | 2018 |
|
RU2706116C1 |
| METHOD OF DIAGNOSTICS OF AUTOIMMUNE VIOLENT DERMATOSES | 2008 |
|
RU2352947C1 |
